Plasma sphingosine 1-phosphate concentrations and cardiovascular autonomic neuropathy in individuals with type 2 diabetes
Sign Up to like & getrecommendations! Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-69566-y
Abstract: The aim of this study was to test the hypothesis that plasma sphingosine 1-phosphate (S1P) levels are associated with the risk of cardiovascular autonomic neuropathy (CAN) in type 2 diabetes patients. This cross-sectional study included… read more here.
Keywords: plasma s1p; type diabetes; plasma sphingosine; s1p levels ... See more keywords
Correlation between plasma sphingosine-1-phosphate and the occurrence and severity of coronary heart disease in postmenopausal women
Sign Up to like & getrecommendations! Published in 2022 at "Menopause"
DOI: 10.1097/gme.0000000000002004
Abstract: Abstract Objective Sphingosine-1-phosphate (S1P) is a bioactive sphingosine with antiatherosclerotic effects. The incidence of coronary heart disease (CHD) increases significantly among women after menopause. We explored the relationship between plasma S1P levels and the occurrence… read more here.
Keywords: postmenopausal women; occurrence severity; chd; plasma s1p ... See more keywords
Sphingosine 1-Phosphate in Malaria Pathogenesis and Its Implication in Therapeutic Opportunities
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Cellular and Infection Microbiology"
DOI: 10.3389/fcimb.2020.00353
Abstract: Sphingosine 1-Phosphate (S1P) is a bioactive lipid intermediate in the sphingolipid metabolism, which exist in two pools, intracellular and extracellular, and each pool has a different function. The circulating extracellular pool, specifically the plasma S1P… read more here.
Keywords: plasma s1p; therapeutic opportunities; sphingosine phosphate; implication therapeutic ... See more keywords